Cardiac Catheterization of the Left Heart 

  • Author: Roger B Olade, MD, MPH; Chief Editor: Karlheinz Peter, MD, PhD   more...
 
Updated: Jan 10, 2012
 

Background

Although the technique and accuracy of noninvasive testing continue to improve, cardiac catheterization (see the image below) remains the standard for the evaluation of hemodynamics. Cardiac catheterization helps provide not only intracardiac pressure measurements but also measurements of oxygen saturation and cardiac output.[1] Hemodynamic measurements usually are coupled with left ventriculography for the evaluation of left ventricular function and coronary angiography.

The heart catheterization. The heart catheterization.

Coronary angiography remains the criterion standard for diagnosing coronary artery disease (CAD) and is the primary method used to help delineate coronary anatomy.[2] In addition to defining the site, severity, and morphology of lesions, coronary angiography helps provide a qualitative assessment of coronary blood flow and helps identify collateral vessels.

Correlation of the findings from coronary angiography with those from left ventriculography permits identification of potentially viable areas of the myocardium that may benefit from a revascularization procedure. Left ventricular function can be further evaluated during stress by using atrial pacing, dynamic exercise, or pharmacologic agents.

Next

Indications

Cardiac catheterization is undertaken for the diagnosis of a variety of cardiac diseases. As with any invasive procedure that is associated with important complications, the decision to recommend cardiac catheterization must be based on a careful evaluation of the risks and benefits to the patient.

Indications for cardiac catheterization are as follows:

  • Identification of the extent and severity of CAD and evaluation of left ventricular function
  • Assessment of the severity of valvular or myocardial disorders (eg, aortic stenosis or insufficiency, mitral stenosis or insufficiency, and various cardiomyopathies) to determine the need for surgical correction
  • Collection of data to confirm and complement noninvasive studies
  • Determination of the presence of CAD in patients with confusing clinical presentations or chest pain of uncertain origin
Previous
Next

Contraindications

With the exception of patient refusal, there are no absolute contraindications for cardiac catheterization. Clearly, the risk-to-benefit ratio must be considered: any procedure that is associated with some degree of risk should be contraindicated if the information derived from it will be of no benefit to the patient. Relative contraindications are as follows:

  • Severe uncontrolled hypertension
  • Ventricular arrhythmias
  • Acute stroke
  • Severe anemia
  • Active gastrointestinal bleeding
  • Allergy to radiographic contrast
  • Acute renal failure
  • Uncompensated congestive failure (so that the patient cannot lie flat)
  • Unexplained febrile illness or untreated active infection
  • Electrolyte abnormalities (eg, hypokalemia)
  • Severe coagulopathy

Note that many of these factors can be corrected before the procedure, which lowers the risk. Preprocedural risk factor correction always should be considered unless the procedure is being performed in an emergency situation.

Absolute contraindications to radial artery access for left-heart cardiac catheterization include the following:

  • Patients who lack adequate collateral circulation
  • Patients with abnormal results from Allen test or plethysmography
  • Patients who may require an intra-aortic balloon pump
  • Patients who may require devices that are not compatible with sheaths smaller than 7 French
  • Patients with known upper-extremity vascular disease
  • Patients with Buerger disease or severe Raynaud syndrome

Relative contraindications to radial artery access for left-heart cardiac catheterization include the following:

  • Patients with chronic kidney disease who may need an arteriovenous fistula in the future
  • Patients with Raynaud syndrome
  • Women with short stature and weak radial pulses
  • Patients with known severe innominate-subclavian artery disease
  • Patients with known internal mammary grafts contralateral to the site of entry
Previous
 
 
Contributor Information and Disclosures
Author

Roger B Olade, MD, MPH  Medical Director, Providence Health Group

Roger B Olade, MD, MPH is a member of the following medical societies: American College of Occupational and Environmental Medicine and American College of Physicians

Disclosure: Nothing to disclose.

Coauthor(s)

Arshad Safi, MD  Interventional Cardiologist, Franklin County Heart Center

Disclosure: Nothing to disclose.

Olurotimi J Badero, MD  Fellow, Division of Interventional Cardiology, Bridgeport Hospital, Yale University School of Medicine

Olurotimi J Badero, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, American Society of Diagnostic and Interventional Nephrology, American Society of Nephrology, Association of Black Cardiologists, National Kidney Foundation, and Renal Physicians Association

Disclosure: Nothing to disclose.

Chief Editor

Karlheinz Peter, MD, PhD  Professor of Medicine, Monash University; Head of Centre of Thrombosis and Myocardial Infarction, Head of Division of Atherothrombosis and Vascular Biology, Associate Director, Baker Heart Research Institute; Interventional Cardiologist, The Alfred Hospital, Australia

Karlheinz Peter, MD, PhD is a member of the following medical societies: American Heart Association, Cardiac Society of Australia and New Zealand, and German Cardiac Society

Disclosure: Nothing to disclose.

Additional Contributors

Gregory J Dehmer, MD Director, Division of Cardiology, Scott & White Healthcare; Professor of Medicine, Texas A&M Health Science Center College of Medicine

Gregory J Dehmer, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, Society for Cardiac Angiography and Interventions, and Society of Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

George A Stouffer III, MD Henry A Foscue Distinguished Professor of Medicine and Cardiology, Director of Interventional Cardiology, Cardiac Catheterization Laboratory, Chief of Clinical Cardiology, Division of Cardiology, University of North Carolina Medical Center

George A Stouffer III, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American Heart Association, Phi Beta Kappa, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

References
  1. Braunwald E, Gorlin R, McIntosh HD, Ross RS, Rudolph AM, Swan HJ. Cooperative study on cardiac catheterization. Summary. Circulation. May 1968;37(5 Suppl):III93-101. [Medline].

  2. Grossman W, Baim DS. Grossman's Cardiac Catheterization, Angiography, and Intervention. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000.

  3. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. Feb 11 2002;162(3):329-36. [Medline].

  4. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. May 19 2004;291(19):2328-34. [Medline].

  5. Saito S, Tanaka S, Hiroe Y, Miyashita Y, Takahashi S, Satake S. Usefulness of hydrophilic coating on arterial sheath introducer in transradial coronary intervention. Catheter Cardiovasc Interv. Jul 2002;56(3):328-32. [Medline].

  6. Coppola J, Patel T, Kwan T, Sanghvi K, Srivastava S, Shah S, et al. Nitroglycerin, nitroprusside, or both, in preventing radial artery spasm during transradial artery catheterization. J Invasive Cardiol. Apr 2006;18(4):155-8. [Medline].

  7. De Ponti R, Marazzi R, Picciolo G, Salerno-Uriarte JA. Use of a novel sharp-tip, J-shaped guidewire to facilitate transseptal catheterization. Europace. Mar 12 2010;[Medline].

  8. Wyman RM, Safian RD, Portway V, Skillman JJ, McKay RG, Baim DS. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol. Dec 1988;12(6):1400-6. [Medline].

  9. Magno P, Loureiro J, Marques A, et al. Ischemic stroke complicating cardiac catherization: case report. Rev Port Cardiol. Oct 2007;26(10):1033-42. [Medline].

  10. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. May 1999;33(6):1756-824. [Medline].

  11. Rezkalla SH. Contrast nephropathy. Clin Med Res. Oct 2003;1(4):301-4. [Medline].

  12. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. Nov 1990;89(5):615-20. [Medline].

  13. Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med. Nov 3 2009;151(9):631-8. [Medline].

  14. Bokhari SS, O'Neill WW, Cohen MG. A tale of two pressures: a case of pseudo-prosthetic mitral valve stenosis. Catheter Cardiovasc Interv. Dec 1 2011;78(7):1022-8. [Medline].

  15. Zimmerman HA, Scott RW, Becker NO. Catheterization of the left side of the heart in man. Circulation. Mar 1950;1(3):357-9. [Medline].

Previous
Next
 
The heart catheterization.
Acute severe mitral regurgitation. Image courtesy of Olurotimi Badero, MD, FACP and www.tctmd.com.
Cardiac catheterization sites.
Femoral access. Image courtesy of Olurotimi Badero, MD, FACP and www.tctmd.com.
Mitral stenosis tracings. Image courtesy of Olurotimi Badero, MD, FACP, and www.tctmd.com.
Aortic stenosis tracings. Image courtesy of Olurotimi Badero, MD, FACP, and www.tctmd.com.
Angiogram showing the left main bifurcating into the left anterior descending (LAD) and the left circumflex (LCX) arteries. Image courtesy of Olurotimi Badero, MD, FACP, and www.tctmd.com.
Hypertrophic obstructive cardiomyopathy (HOCM) showing left ventricular outflow tract gradient at pull back. Image courtesy of Olurotimi Badero, MD, FACP, and www.tctmd.com.
Aortogram obtained with a 6F pigtail catheter showing the ascending aorta, descending aorta, and great vessels. Image courtesy of Olurotimi Badero, MD, FACP.
Chronic total occlusion of the right coronary artery (RCA). Image courtesy of Olurotimi Badero, MD, FACP.
Recanalized chronic total occlusion (CTO) of the right coronary artery (RCA) after percutaneous coronary intervention. Image courtesy of Olurotimi Badero, MD, FACP.
Judkins left 4 (JL4) catheter in place. Image courtesy of Olurotimi Badero, MD, FACP.
Judkins right 4 (JR4) catheter in place. Image courtesy of Olurotimi Badero, MD, FACP.
Left ventriculogram using a 6F pigtail catheter. Image courtesy of Olurotimi Badero, MD, FACP.
Stents in the left anterior descending (LAD) and left circumflex (LCX) arteries. Image courtesy of Olurotimi Badero, MD, FACP.
Left ventriculogram showing mid cavity obliteration in hypertrophic cardiomyopathy (HOCM). Image courtesy of Olurotimi Badero, MD, FACP.
Angiogram showing totally occluded left main coronary artery distally. Image courtesy of Olurotimi Badero, MD, FACP.
Angiogram showing recanalized left main coronary artery with critical trifurcation lesion involving the distal left main coronary artery. Image courtesy of Olurotimi Badero, MD, FACP.
Image showing catheter advancing into the ascending aorta via the right radial artery in the transradial approach. Note the tortuous aorta. Image courtesy of Tak W. Kwan, MD
Transradial cardiac angiogram showing pigtail catheter in the ascending aorta via a retro-esophageal subclavian artery (arteria lusoria). Image courtesy of Olurotimi Badero, MD, FACP.
Tortuous brachiocephalic artery. Image courtesy of Olurotimi Badero, MD, FACP.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.